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Abstract
The stress-induced kinase, c-Jun-N-terminal kinase 1 (JNK1) has previously been impli-
cated in the pathogenesis of lung fibrosis. However, the exact cell type(s) wherein JNK1
exerts its pro-fibrotic role(s) remained enigmatic. Herein we demonstrate prominent activa-
tion of JNK in bronchial epithelia using the mouse models of bleomycin- or AdTGFβ1-
induced fibrosis. Furthermore, in lung tissues of patients with idiopathic pulmonary fibrosis
(IPF), active JNK was observed in various regions including type I and type II pneumocytes
and fibroblasts. No JNK activity was observed in adjacent normal tissue or in normal control
tissue. To address the role of epithelial JNK1, we ablated Jnk1 form bronchiolar and alveolar
type II epithelial cells using CCSP-directed Cre recombinase-mediated ablation of LoxP-
flanked Jnk1 alleles. Our results demonstrate that ablation of Jnk1 from airway epithelia
resulted in a strong protection from bleomycin- or adenovirus expressing active transforming
growth factor beta-1 (AdTGFβ1)-induced fibrosis. Ablation of the Jnk1 allele at a time when
collagen increases were already present showed a reversal of existing increases in collagen
content. Epithelial Jnk1 ablation resulted in attenuation of mesenchymal genes and proteins
in lung tissue and preserved expression of epithelial genes. Collectively, these data suggest
that epithelial JNK1 contributes to the pathogenesis of pulmonary fibrosis. Given the pres-
ence of active JNK in lungs from patients with IPF, targeting JNK1 in airway epithelia may
represent a potential treatment strategy to combat this devastating disease.
Introduction
Organ fibrosis has been estimated to contribute to 45% of all causes of mortality [1] and con-
tributes to kidney, liver, and heart failure. Idiopathic Pulmonary Fibrosis (IPF) is a devastating
disease that kills approximately 40,000 people in the USA each year, with a survival time of 3–5
years upon diagnosis. The causes of IPF remain incompletely understood, but it is thought
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that the disease manifests in setting of aging, as a result of repeated and diverse injuries to the
lung. The exact biochemical and cellular pathways that culminate in excessive extracellular
matrix deposition and alveolar remodeling are a topic of intense investigation, and encompass
death of, or injury to, airway epithelial cells and a failure to regenerate alveolar epithelia,
altered immune cell activation, with an alternative, M2-polarized macrophage signature, and
excessive accumulation of myofibroblasts. Activated myofibroblasts are thought to be the pre-
dominant source of production of excessive extracellular matrix, although collagen secretion
by alveolar epithelial cell also has been shown to contribute to fibrosis in mouse models [2, 3].
The role of epithelial cells in pulmonary fibrosis has clearly emerged. Certain patients with
familial IPF have mutations in SpA and SpC genes, and accumulation of misfolded proteins in
alveolar epithelial cells has been shown to contribute to endoplasmic reticulum stress [4] and
enhanced susceptibility to bleomycin-induced injury [5] and fibrosis [6].The mucin gene,
mucin 5B (Muc5b) expressed in distal airways, also has been strongly linked to pulmonary
fibrosis [7]. The induction of epithelial cell death using an antibody that activates the death
receptor, Fas (CD95) [8, 9], or transgenic approaches encompassing diphtheria toxin, or diph-
theria toxin receptor targeting bronchiolar or type II epithelial cells [10], are sufficient to
induce pulmonary fibrosis in rodents. Furthermore, activation of a partial epithelial to mesen-
chymal transition (EMT) phenotype in epithelial cells and resultant production of collagen [2]
may also constitute a source of ECM in pulmonary fibrosis. While partial EMT is believed to
be important to allow repair following acute injury, repeated activation of partial EMT-like
responses in epithelial cells may contribute to the pathogenesis of fibrosis through the release
of ECM proteins by epithelial cells, without providing a source of fibroblasts [11]. Lastly,
altered progenitor function and/or plasticity of epithelial cells also has been associated with
IPF, based on the emergence of distinct populations of epithelial cells in patients with IPF
characterized by unique RNA expression profiles that suggest intermediate populations,
including cells with basal cell characteristics [12]. Lineage negative epithelial cells (LNEP)
expressing keratin-5 and p63 [13, 14] also contribute to enhanced populations of epithelial
cells in bleomycin-injured lungs, suggesting that airway epithelial cells contribute to alveolar
remodeling and/or repair.
c-Jun-N-terminal kinase (JNK), also known as stress activated protein kinase, as its name
implies, can be induced by a wide variety of stresses. The JNK pathway is a prominent regula-
tor of cell death, and in some settings is a major driver of apoptosis. Our laboratory has previ-
ously shown that JNK1 (but not JNK2) is a major regulator of TGFβ-induced epithelial to
mesenchymal transition [15], in association with phosphorylation of SMAD3 [16]. JNK1 also
promotes Wnt-3-induced EMT via regulation of beta-catenin [17]. Mice that globally lack
Jnk1 (but not Jnk2) were protected from bleomycin-induced fibrosis, or fibrotic remodeling in
a model of allergic airways disease [18]. Most recently we demonstrated that JNK1 contributes
to production of ECM proteins in basal cells stimulated with TGFβ1, notably of laminin and
fibronectin [19]. We furthermore showed that JNK1 contributes to augmentation of an array
of mesenchymal genes in basal cells plated on a provisional ECM derived from TGFβ1-stimu-
lated basal cells, and that the provisional ECM activated JNK1 in a Rho Kinase-dependent
manner.
Despite these earlier observations, which collectively implicated a role of epithelial JNK1,
the role of JNK1 within airway epithelial cells in the pathogenesis of pulmonary fibrosis
remains unknown. Using bleomycin and adenovirus expressing active transforming growth
factor beta-1 (TGFβ1) in mice, we show prominent activation of JNK in bronchial epithelia, as
well as parenchymal regions. In order to unravel the impact of epithelial JNK1 on the patho-
genesis of fibrosis, we therefore ablated Jnk1 in airway epithelial cells, using a club cell
Epithelial JNK1 in airway fibrosis
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secretory protein (CCSP) promoter (also known as secretoglobin family 1A member 1,




All chemicals utilized were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise
noted. Antibodies: Total JNK (#9252), phospho-JNK (#9251) antibodies were obtained from
Cell Signaling Technology (Danvers, MA) (all anti Rabbit, 1:1000), antibodies for S100a4
(FSP1) (sc-19949, anti-Goat, 1:500) and actin (sc-8432, anti-mouse 1:5000) were from Santa
Cruz Biotechnology (Santa Cruz, CA), antibodies for CCSP (anti goat 1:4000) were a kind gift
from Dr. B. Stripp, Cedars-Sinai Medical Center, Los Angeles, CA).
Human lung tissues
Paraffin-embedded lung tissue samples from IPF patients (n = 5, 3 males and 2 females) and
non-diseased controls (n = 5, 3 males and 2 females) were obtained from the National Heart
Lung and Blood Institute-sponsored Lung Tissue Research Consortium (LTRC). The clinical
data and specimens have been de-identified by the LTRC. LTRC protocols were approved by
the Institutional Review Board Committee on Human Research in Medical Sciences (CHRMS
# M14-469) at the University of Vermont.
Phospho-JNK staining human lung tissues
Paraffin sections were cut from formalin-fixed and paraffin-embedded tissue. pJNK was
detected using a polyclonal antibody against rabbit pJNK (#44-682G, Invitrogen, Carlsbad,
CA, USA). pJNK staining was performed on lung sections after antigen retrieval by incubation
of slides for 20 minutes in 0.01M sodium citrate pH 6.0 at 95ºC. Slides were then blocked with
2% normal goat serum for 30 minutes, followed by incubation with the antibody against p-
JNK (1:250 dilution) overnight at 4ºC. After application of biotin-conjugated swine anti-rabbit
IgG Ab (DakoCytomation, Glostrup, Denmark) and alkaline phosphatase-labeled avidin–bio-
tin complex (Vector, Burlingame, CA, USA), enzymatic reactivity was visualized using the
Vector Blue Substrate Kit (Vector). Sections were counterstained with Nuclear Fast Red (Vec-
tor) and mounted. Pictures were taken with a Leica VERSA whole slide image scanner at 400x
magnification (Purchased with the aid of a University of Vermont College of Medicine Shared
Instrumentation Award)
Animals
Mice with a germ-line mutation in the Jnk1 gene with LoxP elements inserted into two differ-
ent introns (Jnk1LoxP) [20] were crossed with CCSP-rtTA and TetO-Cre bi-transgenic mice, in
order to create CCSP-rtTA/tetO-Cre/ Jnk1loxP/loxP genotype. CCSP-rtTA and TetO-Cre trans-
genic mice were a gift from Dr. Whitsett (University of Cincinnati College of Medicine, Cin-
cinnati, OH)[21]. The first generation CCSP-rtTA transgene was used in the present studies.
For all experiments, age-matched male and female mice were used and all experimental mice
where 8–10 weeks old at the initiation of the studies. CCSP-rtTA/tetO-Cre/Jnk1 loxP/loxP were
fed doxycycline (Dox) containing chow (6 g/kg TestDiet, Richmond, IN) in order to delete
JNK1 in CCSP and SPC positive cells (ΔEpi Jnk1). Control mice were age-matched transgene-
negative littermates (WT), or bi-transgenic mice expressing CCSP-rtTA/tetO-Cre transge-
nenes along with the JNK1 WT allele (WT-Jnk1) and were fed dox to control for potential off
Epithelial JNK1 in airway fibrosis
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target effects of dox, or expression of the rtTA tetO-Cre transgenes [21]. An additional control
consisted of mice consisting all three CCSP-rtTA/tetO-Cre/Jnk1loxP/loxP transgenes, in which
dox-food was withheld (Jnk1 loxP). In order to confirm ablation of JNK1 from lung epithelial
cells following administration of doxycycline (dox), single cell suspensions were prepared for
flow cytometric evaluation as described previously [22]. The EpCAM positive, CD45 negative,
Sca1-low fraction of lung cells was sorted (representing epithelial cells), and JNK1 content was
assessed in this fraction and compared to the CD31/34/45+ fraction, representing other non-
epithelial lung cell types. Mice were housed with a 12-h:12-h light/dark cycle and allowed free
access to standard laboratory chow and water. The Institutional Animal Care and Use Com-
mittee at the University of Vermont approved all animal studies. Experiments were repeated at
least once and numbers of animals in each study are indicated in each Figure Legend.
Mouse models of fibrosis
Bleomycin (5U/kg body weight) or 5X108 PFU recombinant AdTGFβ1223/225 (provided by
Dr. Jack Gauldie, McMaster University) was administered oropharyngeally, as described previ-
ously [18, 23]. PBS (Bleomycin) or Ad5 adenovirus (adTGFβ1) (Vector Biolabs, Philadelphia,
PA), were administered as respective controls. Fibrosis was evaluated in mice 3 weeks post
administration of bleomycin or AdTGFβ1. In selected experiments doxycycline was adminis-
tered 7 days before the treatment of profibrotic agents. Mice were maintained on dox food
until the completion of the experiment. In the delayed ablation regimens, dox food was with-
held until 14 days after administration of AdTGFβ1 and thereafter mice were maintained on
Dox food until completion of the experiment. Schematics depicting the time courses of JNK1
ablation, pro-fibrotic agent exposure and euthanization are included in S1 Fig (S1 Fig).
Assessment of fibrosis
Lung sections were stained with Masson’s trichrome reagent to stain collagen, causing a blue
staining of collagen. Slides were scored using a scale of 0 to 3 (0 being the least stain intensity,
3 the highest intensity) for collagen deposition by two independent, blinded investigators. The
cumulative score from each mouse was then averaged according to treatment group. Total
lung collagen was measured in the right middle lobe of the lung after overnight digestion with
10 mg/ml pepsin in 0.5 M acetic acid using the Sircol Assay (Biocolor, UK) as directed by the
manufacturer. As an independent measure of fibrosis, we also measured hydroxyproline con-
tent in the right superior lung lobe [24].
Assessment of airway mechanics
Mice were anesthetized with intraperitoneal pentobarbital sodium (90mg/kg), tracheotomized,
and mechanically ventilated at 200 breaths/min with a tidal volume of 0.25 ml and positive
end-expiratory pressure of 3cmH2O (FlexiVent; SCIREQ, Montreal, Quebec, Canada). Tissue
elastance (H) was measured as a measure of the stiffness of the lung [25, 26].
Homogenization of cell and lung tissue and Western blotting
Protein lysates were prepared by harvesting cells or mincing lung tissue in cold lysis buffer
immediately followed by homogenization as previously described [16, 18]. Lysates were incu-
bated on ice for 30 min, followed by 30 min of centrifugation at 16,000 g. A portion of the
supernatant was saved for protein determination, before the addition of Laemmli sample
buffer. Total protein was assessed by the Bio-Rad DC Protein Assay kit (Bio-Rad). Total JNK1/
2, phospho JNK1/2, and β-actin protein abundance were evaluated by Western blotting. Two
Epithelial JNK1 in airway fibrosis
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dominant bands of JNK immunoreactivity are detected in Western blots, each of which con-
tain both JNK1 and JNK2 which are not fully resolved using conventional Western blotting
procedures. The top band preferentially contains JNK2 while the lower band preferentially
contains JNK1 [16], as is indicated in the figures.
Gene expression
Total RNA was isolated from mouse lungs, using the RNeasy mini-kit (Qiagen, Valencia, CA)
as directed by the manufacturer. Isolated RNA was subjected to reverse transcription and
DNase treatment to produce cDNA for Taqman gene analysis using SYBR green. PCR data
were analyzed by using the ΔΔCt method of relative quantification. Primer sequences were
taken from GeneBank. All accession numbers are listed in Table 1.
Statistical analysis
Data were evaluated by one-way ANOVA using the Tukey test to adjust for multiple compari-
sons. Results with a P-value less than 0.05 or smaller were considered statistically significant.
Nonparametric exact permutation tests were conducted using SPSS Version 19.0.
Results
Increases in pJNK immunoreactivity in airway epithelial cells in fibrotic
lung tissues
We first sought to demonstrate that phosphorylation of JNK, indicative of its activation,
occurred in lung tissue using two different mouse models of fibrotic lung remodeling, bleomy-
cin, and adenovirus expressing active transforming growth factor beta 1 (AdTGFβ1, Fig 1A
and 1B). Administration of either bleomycin or AdTGFβ1 in mice results in both parenchymal
and subepithelial fibrosis [18]. In mice exposed to AdTGFβ1 or bleomycin, phosphorylation of
JNK (pJNK) was increased in homogenized lung tissue (Fig 1A). Of note, two prominent
Table 1. Primer sequences used in real time PCR analyses.
Gene Accession Sequences (5´! 3´) Amplicon (bp)
Hmga2 NM_010441 forward aaggcagcaaaaacaagagc 121
reverse gcaggcttcttctgaacgac
Acta2 (α-SMA) NM_007392.2 forward ctgacagaggcaccactgaa 160
reverse catctccagagtccagcaca




NM_009864.2 forward agccattgccaagtacatcc 133
reverse aaagaccggctgggtaaact
Col1A1 NM_007742.3 forward gagcggagagtactggatcg 103
reverse gttcgggctgatgtaccagt
Vim (Vimentin) NM_011701.4 forward tgaaggaagagatggctcgt 100
reverse tccagcagcttcctgtaggt
Scgb1a1(CCSP) NM_011681.2 forward atctgcccaggatttcttca 150
reverse ctcttgtgggagggtatcca
Tjp1 (ZO-1) NM_009386.2 forward ccacctctgtccagctcttc 249
reverse caccggagtgatggttttct
Sftpc (SPC) NM_011359.2 forward cagctccaggaacctactgc 121
reverse agcttagaggtgggtgtgga
https://doi.org/10.1371/journal.pone.0226904.t001
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bands were detected via Western blot analysis, each representing splice variants of JNK1 and
JNK2, the top band mainly representing JNK2 (JNK2/1), while the lower band mainly repre-
sents JNK1 (JNK1/2). Immuno-reactivity of the lower JNK band was more prominently
increased compared to the upper band, consistent with activation of JNK1. Confocal micros-
copy analysis demonstrated strong increases in pJNK immunofluorescence both within airway
epithelium and parenchymal regions, the latter potentially reflecting type II epithelial cells.
Dual staining of p-JNK and CCSP indeed demonstrated strong co-localization of p-JNK and
CCSP in mice with AdTGFβ1- or bleomycin-induced fibrosis. (Fig 1B). In order to corrobo-
rate these observations, we next evaluated pJNK immuno-localization in 5 different patients
with idiopathic pulmonary disease (IPF) as well as 5 non-IPF lungs (normal). Evaluation of the
staining by a board-certified pulmonary pathologist revealed that pJNK staining was readily
apparent in multiple cell types, including epithelial cells (type I and II alveolar pneumocytes)
in patients with IPF (Fig 1C). pJNK reactivity was also observed in fibroblasts and inflamma-
tory cells in IPF lung. Little or no staining was found in normal control tissue or in adjacent
normal lung tissue from IPF patients. Overall, these data demonstrate increases in pJNK in
epithelial cells in two different models of fibrotic airway and parenchymal remodeling, as well
as in areas of remodeling in patients with IPF.
Epithelial-specific ablation of JNK1 protects against fibrotic remodeling
In order to conclusively determine the contribution of epithelial JNK1 in fibrotic remodeling,
we selectively ablated JNK1 from bronchiolar (CCSP-expressing) epithelial cells and from type
II cells (Fig 2A–2C). We chose this approach due to the prominent reactivity of JNK in CCSP
expressing cells, and to ensure targeting of distal epithelial cells, given the reactivity of JNK in
parenchymal regions (Fig 1). Following administration of doxycycline (dox), JNK1 was selec-
tively ablated from the epithelial fraction of lung cells (ΔEpi Jnk1, Fig 2B).
We next administered dox to mice one week prior to oropharyngeal administration of bleo-
mycin (Fig 3A–3E). Ablation of JNK1 from airway epithelial cells resulted in an almost com-
plete protection from the development of bleomycin-induced fibrosis, as evidenced by the
strong diminution of hydroxyproline (Fig 3A), masson’s trichrome-reactive material (Fig 3B),
collagen content, measured with picrosirius red reagent (Fig 3C) and quantification of mas-
son’s trichrome reactivity (Fig 3D). While bleomycin led to increases in tissue elastance in WT
mice, these increases were not observed in mice lacking epithelial JNK1 (Fig 3E). We next
addressed whether a similar protective effect of ablation of epithelial JNK1 occurred in the
AdTGFβ1-model of fibrosis given our prior observations that JNK1 augments TGFβ1-signal-
ing in airway epithelial cells [16]. Administration of dox one week prior to AdTGFβ1 also
almost completely prevented AdTGFβ1-mediated increases in hydroxyproline content (Fig
4A) Masson’s trichrome reactive material (Fig 4B), lung collagen content (Fig 4C), and
increases in the masson’s trichrome score (Fig 4D), similar to our observations in the bleomy-
cin model. In the absence of dox-containing food, mice containing the Jnk1LoxP/LoxP, CCSP-
rtTA, and TetO-Cre alleles showed increases in fibrosis in response to AdTGFβ1 or bleomycin
Fig 1. Phospho-JNK immunoreactivity is increased in lung tissues in settings of airways and parenchymal fibrosis. (A) p-JNK in lung tissue derived
from mice with bleomycin or adTGFβ1-induced pulmonary fibrosis. Mice were exposed to agents, and respective vehicle controls (con), and 3 weeks
thereafter, lung tissues were homogenized for the assessment of pJNK via Western blot analysis. PBS or control-adenoviral vector exposed mice resulted in
similar lack of p-JNK immunoreactivity (see Fig 1B below), and therefore only one representative control group (Con) is shown. (B) Immunolocalization of
p-JNK (red) in lung tissue from mice 3 weeks after exposure to a representative vehicle control, bleomycin or adenovirus expressing recombinant active
transforming growth factor beta-1 (adTGFβ1). Lower Panels; Co-localization of p-JNK with CCSP in control vehicle, bleomycin or adTGFβ1. Results were
evaluated via confocal microscopy. Co-localization of p-JNK and CCSP is indicated by a yellow color. Scale bars: 50 μm. (C) p-JNK (blue) in lung tissue from
patients with idiopathic pulmonary fibrosis (IPF) or non-IPF lung (Normal, n = 5 patients/group). Scale bars: 300 μm.
https://doi.org/10.1371/journal.pone.0226904.g001
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that were indistinguishable from WT transgene negative animals (Fig 4E). Overall, these find-
ings demonstrate that ablation of JNK1 in airway epithelia provides protect against the devel-
opment of fibrosis using two independent models.
We next addressed the impact of epithelial ablation of JNK1 on expression profiles of epi-
thelial and mesenchymal genes and mesenchymal proteins in homogenized lung tissues from
bleomycin- or AdTGFβ1-exposed mice (Figs 5 and 6, respectively). As expected, increases in
expression of mesenchymal genes or proteins and decreases in epithelial genes were observed
in lung tissues from WT animals subjected to bleomycin (Fig 5A–5C). Importantly the
increased mesenchymal profile induced by bleomycin was almost completely prevented in
mice with epithelial specific ablation of JNK1 (Fig 5A and 5C). Conversely, decreases in
mRNA expression of the epithelial markers Scgb1a1 (CCSP), Cdh1 and Tjp-1 observed in WT
mice in response to bleomycin, were ameliorated in mice lacking epithelial JNK1 (Fig 5B). We
corroborated these findings using AdTGFβ1, and showed a similar diminution of mesenchy-
mal genes and proteins, following ablation of epithelial JNK1, along with a protection from
decreases in expression of the epithelial genes,) Cdh1 and Tjp-1 (Fig 6A–6C). These findings
implicate epithelial JNK1 as a critical contributor in the development of fibrosis, in association
with attenuation of epithelial gene expression profiles, while promoting a mesenchymal
expression signature.
Delayed epithelial specific ablation of JNK1 protects against fibrotic
remodeling
We next addressed whether ablation of epithelial JNK1 plays a role in the progression of fibrosis.
We therefore first administered AdTGFβ1, and 2 weeks thereafter verified that collagen was
increased in lung tissue (Fig 7A and 7B). At that time, we initiated ablation of epithelial JNK1
with dox-containing food, and assessed collagen deposition 4 weeks thereafter (Fig 7A–7C).
AdTGFβ1-mediated increases in collagen deposition were almost completely reversed upon
delayed ablation of JNK1 from airway epithelium (Δ-epi-JNK1) (Fig 7A–7C). In the absence of
dox, collagen content increased slightly between weeks 2 and 6 in mice carrying the JNK1LoxP/
LoxP, CCSP-rtTA, and TetO-Cre transgenes (JNK1loxP, Fig 7A). Furthermore, dox feeding of
mice carrying CCSP-rtTA, and TetO-Cre transgenes but WT JNK1 alleles (WT-JNK1) developed
fibrosis similar to transgene negative WT littermates (Fig 7C). Similar to earlier observations,
expression of the mesenchymal genes, Col1a1, and Acta2 (α-SMA) was strongly decreased while
Cdh1 expression was restored to control levels following delayed ablation of epithelial Jnk1, com-
pared to WT mice subjected to AdTGFβ1 (Fig 7D). Collectively, these findings demonstrate that
presence of JNK1 within the airway epithelium at a time when increases in collagen deposition
are already apparent, plays a crucial role in sustaining fibrotic airway remodeling in association
with repressed epithelial, and enhanced mesenchymal expression profiles.
Conclusion
Pulmonary fibrosis has been associated with the activation of diverse signaling pathways that
affect multiple cell types. The JNK pathway, notably JNK1, had previously been implicated in
Fig 2. Depiction of the conditional ablation strategy of JNK1 from lung epithelial cells. (A) Schematic of JNK1 ablation from airway epithelial cells using
transgenic mice expressing CCSP-rtTA, TetO-Cre, and Jnk1loxP/loxP alleles. Upon feeding doxycycline (dox)- containing food, JNK1 is ablated from airway
epithelial cells, designated as ΔEpi Jnk1. (B) Confirmation of ablation of JNK1 in airway epithelial cells. 3 weeks after initiation of Dox feeding, single cells lung
suspensions were created and cells were sorted by flow cytometry. The EpCAM positive, CD45 negative, Sca1 low fraction of lung cells was isolated for assessment
of JNK1 expression via Western Blot analysis. Note that JNK1 was only ablated from the EpCAM positive, CD45 negative, Sca1low fraction of lung cells. (C)
Visualization of Cre-recombination in CCSP-rtTA, TetO-Cre-expressing mice which were bred with Tomato red reporter mice. Red: Cre-expressing cells. Scale
bars: 50 μm.
https://doi.org/10.1371/journal.pone.0226904.g002
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the pathogenesis of pulmonary fibrosis, based upon observations that mice globally lacking
JNK1, but not JNK2, were protected from the development of bleomycin-induced fibrosis.
Deletion of JNK1 had no impact on recruitment of inflammatory cells observed after adminis-
tration of bleomycin [18]. The exact cell types wherein JNK activation occurs and contributes
to disease pathogenesis remained unclear as JNK activation both in epithelial cells [27] as well
as fibroblasts [28] had been suggested as potential contributors to the pathogenesis of fibrosis.
As was stated above, JNK1 had been linked to the epithelial mesenchymal transition induced
by TGFβ1 or Wnt3a [15, 17]. Similarly, JNK1 also had been implicated in myofibroblast activa-
tion [29]. We demonstrated herein that in mouse models of fibrosis, JNK activation occurred
in bronchial epithelial cells, as well as parenchymal regions within the lung. JNK activation
was also observed in type I and II epithelial cells, fibroblast and inflammatory cells in lung tis-
sues from patients with IPF. We furthermore demonstrated that ablation of JNK1 in bronchial
and type II epithelial cells, using a CCSP promoter to express Cre Recombinase to remove the
loxP-flanked Jnk1 allele, affords strong protection against fibrosis induced by bleomycin or
AdTGFβ1. Significantly, epithelial ablation of JNK1 at a time where collagen was already
increased resulted in reversal of AdTGFβ1-induced fibrosis.
Altered plasticity of epithelial cells and failure to regenerate the alveolar epithelium consist-
ing of type II and type I epithelial cells is an important feature of pulmonary fibrosis, with reac-
tive type II epithelial cells and areas of bronchiolarization occurring in lungs from patients
with IPF [27]. RNA profiling in individual epithelial cells from patients with IPF identified
multiple distinct epithelial gene signatures, with features of mixed basal and alveolar character-
istics, indicative of altered plasticity, and inadequate alveolar repair [30]. Results from our cur-
rent studies fail to pin point the exact location wherein JNK1 is operative to contribute to
fibrosis, given that we used the a CCSP expression cassette that is expressed both in bronchio-
lar epithelial cells and distal epithelia, likely representing type II cells [21]. It also is not clear
how JNK1 mechanistically controls pathways that govern epithelial plasticity. JNK1 can regu-
late both Smad and Wnt-signaling pathways, which has been implicated in epithelial cell fate,
and epithelial plasticity [16, 17, 31]. Additional studies will be required to elucidate whether
Wnt is a pro-fibrotic target of JNK1.
We recently showed that JNK1 activity in airway basal cells contributes to their mesenchy-
mal activation, indicative of partial EMT, when these cells were plated on a provisional matrix
derived from TGFβ1-stimulated basal cells, or on a fibronectin or laminin matrix [19]. Basal
cells plated onto a decellularized lung scaffold prepared from control mice showed no evidence
of JNK activation and retained expression of p63 and keratin 5. Interestingly, these cells also
begun to express CCSP, indicative of their differentiation into secretory cells. In contrast, basal
cells plated onto a decellularized scaffold prepared from lungs of mice with bleomycin-induced
fibrosis showed JNK activation, enhanced expression of mesenchymal genes and proteins, and
loss of epithelial genes along with decreases in expression of p63 and keratin 5. Basal cells lack-
ing JNK1 were resistant to this loss of “epithelial-ness”, and similar protective effects were
Fig 3. Conditional ablation of JNK1 from lung epithelial cells attenuates lung fibrosis induced by bleomycin. JNK1 was selectively
ablated from the bronchiolar epithelial cells and type II cells using a CCSP promoter driving a reverse tetracycline activator (rtTA), the
tetracyclin operon driving CRE recombinase (TetOP-Cre), and mice carrying a LoxP-flanked Jnk1 allele. Assessment of total collagen
content in lung tissue 3 weeks following administration of bleomycin via hydroxyproline content (A), Masson’s trichrome staining (B),
Sircol assay (C) and semi-quantitative evaluation of Masson’s trichrome reactive material (D). (E) Assessment of tissue elastance in mice
exposed to bleomycin, and the impact of ablation of epithelial JNK1. ΔEpi Jnk1 mice or respective control groups, as described in the
methods section were fed dox food for one week prior to exposure to bleomycin. 3 weeks post-administration of bleomycin, mice were
evaluated via forced oscillation mechanics to assess tissue elastance. (WT- Jnk1: PBS n = 6, Bleo n = 12, ΔEpi Jnk1: PBS n = 5, Bleo n = 8
respectively mice/group from 2 independent experiments). � p< 0.05 compared to PBS control group. † p< 0.05 compared to respective
WT groups. (ANOVA). Scale bars: 50 μm.
https://doi.org/10.1371/journal.pone.0226904.g003
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Fig 4. Conditional ablation of JNK1 from lung epithelial cells attenuates lung fibrosis induced by adTGFβ1. JNK1 was selectively
ablated from the bronchiolar epithelial cells and type II cells using a CCSP promoter driving a reverse tetracycline activator (rtTA), the
tetracyclin operon driving CRE recombinase (TetOP-Cre), and mice carrying a LoxP-flanked Jnk1 allele. Assessment of total collagen
content in lung tissue 3 weeks following administration of bleomycin via hydroxyproline content (A), Masson’s trichrome staining (B),
Sircol assay (C) and semi-quantitative evaluation of Masson’s trichrome reactive material (D). E: Assessment of pulmonary fibrosis, using
the sircol assay in response to AdTGFβ1 in mice containing the CCSP-rtTA, TetO-Cre, and Jnk1 loxP/loxP alleles, or CCSP-rtTA, TetO-Cre
alleles, in the absence of doxycycline-containing food. (WT- Jnk1: AdCtr n = 6, adTGFβ1 n = 8, ΔEpi Jnk1: AdCtr n = 5, adTGFβ1 n = 8
respectively mice/group from 2 independent experiments). � p< 0.05 compared to the adCtr control groups. † p< 0.05 compared to
respective WT groups. (ANOVA). Scale bars: 50 μm.
https://doi.org/10.1371/journal.pone.0226904.g004
Fig 5. Evaluation of epithelial and mesenchymal gene expression profiles in lungs from ΔEpiJnk1 mice, or control groups subjected to bleomycin-induced lung
fibrosis. Analysis of mesenchymal (A) or epithelial (B) mRNA expression in homogenized lung tissue from mice exposed to bleomycin for 3 weeks. Results were
normalized to the housekeeping gene cyclophilin, and are expressed as fold expression changes (+/- SEM) compared to the WT vehicle control groups. (WT- Jnk1: PBS
n = 6, Bleo n = 12, ΔEpiJnk1: PBS n = 5, Bleo n = 8 respectively mice/group from 2 independent experiments). � p< 0.05 compared to the PBS control group. † p< 0.05
compared to the respective WT group. (ANOVA). C: Evaluation of mesenchymal proteins (α-SMA (Acta2), Col1a1, FSP1 (S100a4)) in lungs from ΔEpiJNK1 mice, or
control groups subjected to bleomycin-induced lung fibrosis, and the impact of ablation of epithelial JNK1. Homogenized lung tissues were subjected to Western blot
analysis for the indicated proteins. β-actin: Loading control. Shown are results from individual mice.
https://doi.org/10.1371/journal.pone.0226904.g005
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observed when JNK1-deficient airway basal cells were plated onto lung scaffolds derived from
patients with IPF. These findings suggest that JNK1 can act as a double-edged sword in the set-
tings of fibrosis. JNK1 can regulate the fibrotic injury process via Smad and Wnt signaling
pathways independent from the inflammatory responses. Conversely, JNK1 is important in
the response of epithelial cells to an altered ECM in settings of pulmonary fibrosis and the sub-
sequent loss of epithelial proteins. Additional studies will be required to identify the precise
molecular targets of JNK1 that regulate the initial fibrotic response versus the ECM-derived
cues and the relative importance of these events within epithelial cells in the pathogenesis of
fibrosis.
Fig 6. Evaluation of epithelial and mesenchymal gene expression profiles in lungs from ΔEpiJNK1 mice, or control groups subjected to adTGFβ1-induced lung
fibrosis. Analysis of mesenchymal (A) or epithelial (B) mRNA expression in homogenized lung tissue from mice exposed to adTGFβ1 for 3 weeks. Results were
normalized to the housekeeping gene cyclophilin, and are expressed as fold expression changes (+/- SEM) compared to the WT vehicle control groups. (WT- Jnk1:
AdCtr n = 6, adTGFβ1 n = 8, ΔEpi Jnk1: AdCtr n = 5, adTGFβ1 n = 8 respectively mice/group from 2 independent experiments). � p< 0.05 compared to the adCtr
control groups. † p< 0.05 compared to respective WT groups. (ANOVA). C: Evaluation of mesenchymal proteins (α-SMA (Acta2) and Col1a1 in lungs from ΔEpi Jnk1
mice or control groups (WT mice) subjected to adTGFβ1-induced lung fibrosis. Homogenized lung tissues were subjected to Western blot analysis for the indicated
proteins. β-actin: Loading control. Shown are results from individual mice.
https://doi.org/10.1371/journal.pone.0226904.g006
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It had been demonstrated previously that the ECM is an important regulator of myofibro-
blast activation [32]. Notably, a fibrotic ECM scaffold was shown to lead to activation of con-
trol fibroblasts, while conversely, plating of activated myofibroblasts derived from IPF patients
onto an ECM scaffold from control lungs resulted into a quiescent phenotype similar to con-
trol fibroblasts, suggesting that ECM is a prominent determinant that dictates fibroblast activa-
tion [33]. The activation of Rho kinase and myocardin-related transcription factor (MRTF)
were shown to be critical mechano-sensing pathways that controlled myofibroblast activation
[34]. Other studies have shown that the YAP/TAZ pathway also regulates the response of
fibroblasts to ECM-derived cues [35]. The extent to which ECM regulates epithelial cell plastic-
ity and the relative importance of the ECM in regulating epithelial cell plasticity or death will
also require further study. Similarly, the role of JNK1 in ECM-controlled activation of epithe-
lial cells, and the molecular targets of JNK herein also require further study. One putative tar-
get of JNK with relevance to mechano-transduction is the 14.3.3 protein, which can be
phosphorylated on Ser 184 [36]. Further, there is compelling evidence for interplay between
JNK and YAP/TAZ signaling pathways. JNK effector activator protein (AP)-1 activity is
reportedly increased by YAP/TAZ through JNK–YAP interaction [37] and YAP/TAZ activa-
tion promotes inflammation and atherogenesis by enhancing JNK [38].
The demonstration that delayed ablation of Jnk1 in epithelial cells prevented the progres-
sion of fibrosis, and more importantly reversed the existing increases in fibrosis in the Adeno
TGFβ1 model of fibrosis indicates the potential therapeutic relevance of targeted inhibition of
JNK1 in fibrosis. Indeed, in a recent study we showed that the JNK inhibitor, CC-930, attenu-
ated bleomycin- and house dust mite- induced pulmonary fibrosis in mice [39, 40] although
pharmacological JNK inhibition did not affect airway mechanics. In this study epithelial JNK1
ablation reduces lung elastance which is in line with the finding by Dolhnikoff et al. who
observed that increased lung elastance in bleomycin-exposed animals correlated with collagen
content [41], lending further support to the notion that modulating JNK might have a positive
physiological effect in fibrotic lung disease. A clinical trial with CC-930 also showed some evi-
dence of a potential clinical response in patients with dermal fibrosis and IPF [40, 42]. How-
ever, the latter trial had to be terminated due to side effects. A new clinical trial using a more
specific JNK1 inhibitor, CC90001, is currently ongoing in patients with IPF (NCT03142191:
clinical trials.gov). The demonstration of a strongly protective effect on ablation of epithelial
JNK1 in fibrosis, linked to the concurrent clinical development of JNK1 inhibitors point to the
potential clinical and translational relevance of our current findings.
Supporting information
S1 Fig. Schematics depicting mouse experiments.
(TIF)
Fig 7. The impact of delayed ablation of epithelial JNK1 in adTGFβ1-induced lung fibrosis. Delayed ablation of JNK1 from lung epithelial cells
reverses existing increases in lung fibrosis induced by AdTGFβ1. Mice expressing either CCSP-rtTA TetO-CRE transgenes along with the WT Jnk1
allele, or CCSP-rtTA, tetO-CRE, Jnk1LoxP/LoxP transgenes (WT Jnk1) were exposed to AdTGFβ1 or AdCtr vector. As a control, CCSP-rtTA, tetO-CRE,
Jnk1LoxP/LoxP transgene expressing mice were kept on regular chow (Jnk1 LoxP). Two weeks thereafter, 3 mice/group were euthanized for assessment
of total lung collagen content while the remainder of animals was administered dox food for an additional 4 weeks prior to assessment of total lung
collagen content. Lung fibrosis was assessed via the Sircol assay (A) or Masson’s Trichrome staining and analysis (B and C). D: Expression of epithelial
and mesenchymal genes in homogenized lung tissue of various groups. (n = WT- Jnk1 and Jnk1 Loxp (no dox) adCtr/adTGFβ1 = 4/4/6/6, WT- Jnk1
and ΔEpi Jnk1 (on dox) adTGFβ1 = 8/11 respectively mice/group from 2 independent experiments). Results were normalized to the housekeeping
gene cyclophilin, and are expressed as fold expression changes (+/- SEM) compared to the WT vehicle control groups. � p< 0.05 compared to PBS or
AdCtr control groups. † p< 0.05 compared to respective WT groups. (ANOVA). Scale bars: 50 μm.
https://doi.org/10.1371/journal.pone.0226904.g007
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